Authors:
CONSTANTINIDOU M
CHALEVELAKIS G
ECONOMOPOULOS T
KOFFA M
LILOGLOU T
ANASTASSIOU C
YALOURIS A
SPANDIDOS DA
RAPTIS S
Citation: M. Constantinidou et al., CODON 12 RAS MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME - INCIDENCE AND PROGNOSTIC VALUE, Annals of hematology, 74(1), 1997, pp. 11-14
Authors:
ECONOMOPOULOS T
PAPAGEORGIOU E
STATHAKIS N
CONSTANTINIDOU M
PARHARIDOU A
KOSTOUROU A
DERVENOULAS J
RAPTIS S
Citation: T. Economopoulos et al., TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES WITH IDARUBICIN AND CYTOSINE-ARABINOSIDE SUPPORTED BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF), Leukemia research, 20(5), 1996, pp. 385-390
Authors:
CONSTANTINIDOU M
CHALEVELAKIS G
ECONOMOPOULOS T
KOFFA M
LILOGLOU T
ANASTASIOU C
YALOURIS A
SPANDIDOS DA
RAPTIS S
Citation: M. Constantinidou et al., RAS MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME - INCIDENCE AND PROGNOSTIC VALUE, Blood, 86(10), 1995, pp. 1329-1329
Authors:
ECONOMOPOULOS T
STATHAKIS N
ALEXOPOULOS C
PAVLIDIS N
CONSTANTINIDOU M
BRIASSOULIS E
PAPAGEORGIOU E
DERVENOULAS J
PAPPA V
VASLAMATZIS M
RAPTIS S
Citation: T. Economopoulos et al., 2ND MALIGNANCIES FOLLOWING TREATMENT FOR HODGKINS-DISEASE - A GREEK EXPERIENCE, Haematologica, 79(3), 1994, pp. 273-276